Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 54.15 and traded as high as GBX 63.20. Beximco Pharmaceuticals shares last traded at GBX 63.20, with a volume of 3,227 shares traded.
Beximco Pharmaceuticals Price Performance
The company has a current ratio of 4.13, a quick ratio of 0.37 and a debt-to-equity ratio of 5.27. The business’s 50 day moving average price is GBX 54.69 and its two-hundred day moving average price is GBX 46.95. The stock has a market cap of £267.67 million, a P/E ratio of 0.03 and a beta of 0.25.
Beximco Pharmaceuticals Company Profile
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
See Also
- Five stocks we like better than Beximco Pharmaceuticals
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
